Doxycycline
FDA Approved
Description
Doxycycline is a tetracycline antibiotic with anti-inflammatory properties. It has been used off-label in the management of amyloidosis to reduce amyloid deposition and inflammation. The drug is well-tolerated and widely available.
Indications & Therapeutic Use
Bacterial infections, anti-inflammatory therapy in amyloidosis, periodontal disease
Global Availability (9 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Doxycycline
| Generic Name | Doxycycline |
| Brands | 1 brand available |
| Active Ingredient | Doxycycline hyclate |
| Drug Class | Bacterial infections |
| Manufacturer | Pfizer |
| Dosage Forms | Oral capsule 50mg, 100mg; Oral tablet 20mg, 100mg; IV infusion 100mg |
| Medical Code | J01AA02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT02125032 |
| Countries | 9 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations10 Validated Nodes